AZN's PACIFIC Proves To Have Depth, ARDX Abuzz, No Flashy Data From ALLSTAR

Today's Daily Dose brings you news about Ardelyx' phase III study results of Tenapanor in irritable bowel syndrome with constipation; Capricor's disappointing mid-stage trial data of CAP-1002; AstraZeneca's encouraging results of Imfinzi in unresectable lung cancer and Ziopharm's public offering.

from RTT - Biotech http://ift.tt/2qeJYY0
via IFTTT